[go: up one dir, main page]

PT1141358E - Ensaio para identificação de compostos que afectam a estabilidade do arnm - Google Patents

Ensaio para identificação de compostos que afectam a estabilidade do arnm Download PDF

Info

Publication number
PT1141358E
PT1141358E PT99962013T PT99962013T PT1141358E PT 1141358 E PT1141358 E PT 1141358E PT 99962013 T PT99962013 T PT 99962013T PT 99962013 T PT99962013 T PT 99962013T PT 1141358 E PT1141358 E PT 1141358E
Authority
PT
Portugal
Prior art keywords
mrna
transfected cells
stably transfected
identifying compounds
affect stability
Prior art date
Application number
PT99962013T
Other languages
English (en)
Inventor
Tania Kastelic
Dominique Cheneval
Original Assignee
Novation Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novation Pharmaceuticals Inc filed Critical Novation Pharmaceuticals Inc
Publication of PT1141358E publication Critical patent/PT1141358E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT99962013T 1998-12-24 1999-12-23 Ensaio para identificação de compostos que afectam a estabilidade do arnm PT1141358E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9828709.7A GB9828709D0 (en) 1998-12-24 1998-12-24 Assay

Publications (1)

Publication Number Publication Date
PT1141358E true PT1141358E (pt) 2008-03-17

Family

ID=10845082

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99962013T PT1141358E (pt) 1998-12-24 1999-12-23 Ensaio para identificação de compostos que afectam a estabilidade do arnm

Country Status (12)

Country Link
US (1) US20150176088A1 (pt)
EP (1) EP1141358B1 (pt)
JP (1) JP2002541767A (pt)
AT (1) ATE380249T1 (pt)
AU (1) AU776604C (pt)
CA (1) CA2356621C (pt)
DE (1) DE69937689T2 (pt)
DK (1) DK1141358T3 (pt)
ES (1) ES2299273T3 (pt)
GB (1) GB9828709D0 (pt)
PT (1) PT1141358E (pt)
WO (1) WO2000039314A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1140069A1 (en) 1998-12-24 2001-10-10 Novation Pharmaceuticals Inc. COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR
US7598079B2 (en) 1998-12-24 2009-10-06 Novation Pharmaceuticals, Inc. Assay for identifying compounds which affect stability of mRNA
AU2002242474B2 (en) * 2001-03-09 2004-05-20 Gene Stream Pty Ltd Novel expression vectors
US7915306B2 (en) 2002-03-08 2011-03-29 Eisai Co., Ltd. Macrocyclic compounds useful as pharmaceuticals
CA2478065C (en) 2002-03-08 2013-01-08 Eisai Co. Ltd. Macrocyclic compounds useful as pharmaceuticals
EP1497327A2 (en) 2002-04-17 2005-01-19 Novartis AG Method for the identification of inhibitors of the binding of are-containing mrna and an hur protein
ATE451454T1 (de) * 2002-09-16 2009-12-15 Promega Corp Schnell abgebaute reporter-fusionsproteine
US8426194B2 (en) 2003-01-21 2013-04-23 Ptc Therapeutics, Inc. Methods and agents for screening for compounds capable of modulating VEGF expression
CA2514184C (en) 2003-01-21 2016-04-12 Ptc Therapeutics, Inc. Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same
US9068234B2 (en) 2003-01-21 2015-06-30 Ptc Therapeutics, Inc. Methods and agents for screening for compounds capable of modulating gene expression
US8076352B2 (en) 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Administration of carboline derivatives useful in the treatment of cancer and other diseases
EA201200555A1 (ru) 2004-03-15 2013-01-30 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Производные карболина, полезные в ингибировании ангиогенеза
US7767689B2 (en) 2004-03-15 2010-08-03 Ptc Therapeutics, Inc. Carboline derivatives useful in the treatment of cancer
US8076353B2 (en) 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Inhibition of VEGF translation
US8283115B1 (en) 2007-06-20 2012-10-09 Ptc Therapeutics, Inc. Methods of screening for compounds for treating muscular dystrophy using UTRN mRNA translation regulation
US8283116B1 (en) 2007-06-22 2012-10-09 Ptc Therapeutics, Inc. Methods of screening for compounds for treating spinal muscular atrophy using SMN mRNA translation regulation
CN105748465A (zh) 2007-07-25 2016-07-13 卫材R&D管理株式会社 用于治疗癌症的多激酶抑制剂
US11576892B2 (en) 2015-08-18 2023-02-14 Novation Pharmaceuticals Inc. Benzopyran derivatives and uses thereof
CN115896099A (zh) * 2016-03-31 2023-04-04 伯克利之光生命科技公司 核酸稳定试剂、试剂盒及其使用方法
CN116426610B (zh) * 2023-06-08 2024-01-05 启辰生生物科技(珠海)有限公司 一种LC-MS法准确定量mRNA加帽效率的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174666B1 (en) * 1992-03-27 2001-01-16 The United States Of America As Represented By The Department Of Health And Human Services Method of eliminating inhibitory/instability regions from mRNA
AU703445B2 (en) * 1994-06-07 1999-03-25 Stryker Corporation Methods and compositions for modulating morphogenic protein expression
US5731343A (en) * 1995-02-24 1998-03-24 The Scripps Research Institute Method of use of radicicol for treatment of immunopathological disorders
JP2002516095A (ja) * 1998-05-26 2002-06-04 ユニヴァーシティー オブ メディシン アンド デンティストリー オブ ニュージャージー Rna分子の安定性およびターンオーバーの再現および調節のためのシステム

Also Published As

Publication number Publication date
WO2000039314A1 (en) 2000-07-06
AU1852200A (en) 2000-07-31
DK1141358T3 (da) 2008-03-31
GB9828709D0 (en) 1999-02-17
EP1141358B1 (en) 2007-12-05
US20150176088A1 (en) 2015-06-25
DE69937689T2 (de) 2008-08-28
CA2356621C (en) 2013-03-26
JP2002541767A (ja) 2002-12-10
ATE380249T1 (de) 2007-12-15
CA2356621A1 (en) 2000-07-06
DE69937689D1 (de) 2008-01-17
AU776604B2 (en) 2004-09-16
EP1141358A1 (en) 2001-10-10
AU776604C (en) 2005-05-12
ES2299273T3 (es) 2008-05-16

Similar Documents

Publication Publication Date Title
PT1141358E (pt) Ensaio para identificação de compostos que afectam a estabilidade do arnm
Zhao et al. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression
AU1926899A (en) Exploiting genomics in the search for new drugs
WO2000056762A3 (en) Methods for monitoring multiple gene expression
WO2002029113A3 (en) Methods for monitoring multiple gene expression
AU4818599A (en) Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12),md-1, md2 and cyclin e2, related reagents and methods
GB9709728D0 (en) Single step method
NO20001497D0 (no) Ekspresjon av endogene gener ved ikke-homolog rekombinasjon av en vektorkonstrukt med cellulært DNA
DE69940265D1 (de) Alzheimersche krankheit sekretase
TR200002446T2 (tr) Fosfolipaz enzimlerinin inhibitörleri
DE59813438D1 (de) Optimierung von Zellen für die endogene Genaktivierung
AUPO128096A0 (en) Biosensors
AU5659898A (en) Gene-trapping construct for the identification and isolation of genes
WO1999050459A3 (en) High throughput in vitro screening assays for transcription modulators
AU2002246792A1 (en) Identification of individual cells during kinetic assays
WO2001072773A3 (en) Genes isolated from dendritic cells, gene products and methods employing the same
NO20003880D0 (no) Transfekterende midler som er sensitive overfor reduserende betingelser, farmasøytiske preparater inneholdende disse samt deres anvendelser
WO2000058521A3 (en) Methods for the identification of reporter and target molecules using comprehensive gene expression profiles
WO2005028677A3 (en) Systems and methods for determining cell type composition of mixed cell populations using gene expression signatures
WO2006128084A3 (en) Trps1-mediated modulation of hair growth
FI972909A0 (fi) Oekad produktion av avsoendrade proteiner genom rekombinatjaestceller
AU5245399A (en) T cell receptor proteins, nucleic acid molecules, and uses thereof
WO2001046468A3 (en) Screening method for ros-induced apoptosis in a cell
WO2002040719A3 (en) Retinoid pathway assays, and compositions therefrom
IL148117A0 (en) Dihydroorotase extracted from plants